BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS

Aspergillus fumigatus colonization in the patients with cystic fibrosis (CF) may cause sensitization against A. fumigatus and/or allergic bronchopulmonary aspergillosis (ABPA), which significantly worsens the course of underlying disease. At the present time, new diagnostic tests are searched for de...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ya. I. Kozlova, E. V. Frolova, A. E. Uchevatkina, L. V. Filippova, O. V. Aak, T. S. Bogomolova, Yu. V. Borzova, V. R. Makhmutova, T. A. Stepanenko, V. D. Kuznetsov, N. V. Vasilyeva, M. V. Shulgina, N. N. Klimko
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2019
Materias:
Acceso en línea:https://doaj.org/article/f29a786a592f4676bdf0ba3fccca289e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f29a786a592f4676bdf0ba3fccca289e
record_format dspace
spelling oai:doaj.org-article:f29a786a592f4676bdf0ba3fccca289e2021-11-18T08:03:49ZBASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS1563-06252313-741X10.15789/1563-0625-2019-5-919-928https://doaj.org/article/f29a786a592f4676bdf0ba3fccca289e2019-12-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1693https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XAspergillus fumigatus colonization in the patients with cystic fibrosis (CF) may cause sensitization against A. fumigatus and/or allergic bronchopulmonary aspergillosis (ABPA), which significantly worsens the course of underlying disease. At the present time, new diagnostic tests are searched for detection of fungal sensitization in these patients. The aim of this work was to evaluate an opportunity of application of basophile activation test with A. fumigatus allergen in vitro using flow cytometry, aiming for identification of fungal sensitization in the CF patients. The study included 190 patients with CF aged 1 to 37 years. All the patients underwent common allergy screening (skin tests with fungal allergens, determination of serum levels of total IgE and specific IgE for the fungal allergens), and mycological examination (microscopy and culture of respiratory substrates). Computed tomography of the chest was performed upon clinical indications. The basophil activation test with the A. fumigatus allergen was performed in 10 CF patients with ABPA, and 10 CF patients without ABPA, in addition to the standard allergological examination. Frequency of sensitization to A. fumigatus in the patients with cystic fibrosis was 27%, the incidence of allergic bronchopulmonary aspergillosis was 5.7%. The number of eosinophils, total IgE and specific IgE levels in CF patients with ABPA were significantly higher than in CF patients without ABPA. In blood of the ABPA patients we have identified 68.5 (52.5-81.5%) of basophilic leukocytes activated by A. fumigatus allergen, with a stimulation index of 17.07 (10.30-27.70). In appropriate comparison group, the stimulation index did not exceed 1.5 (p = 0.000). Direct positive correlation between the levels of specific IgE to A. fumigatus and the number of basophils activated by A. fumigatus allergens was revealed (r = 0.77; р < 0.05). FVC values and the body mass index in CF patients with ABPA were significantly lower when compared with the patients without fungal sensitization. Introduction of the basophil activation test, along with standard techniques, may enable a more differentiated assessment of ABPA development in CF patients. Timely detection of associations between A. fumigatus sensitization and clinical status of CF patients will facilitate early and effective administration of specific therapy.Ya. I. KozlovaE. V. FrolovaA. E. UchevatkinaL. V. FilippovaO. V. AakT. S. BogomolovaYu. V. BorzovaV. R. MakhmutovaT. A. StepanenkoV. D. KuznetsovN. V. VasilyevaM. V. ShulginaN. N. KlimkoSPb RAACIarticlebasophil activation testaspergillus spp.aspergillus fumigatusallergic bronchopulmonary aspergillosiscystic fibrosisfungal sensitizationImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 21, Iss 5, Pp 919-928 (2019)
institution DOAJ
collection DOAJ
language RU
topic basophil activation test
aspergillus spp.
aspergillus fumigatus
allergic bronchopulmonary aspergillosis
cystic fibrosis
fungal sensitization
Immunologic diseases. Allergy
RC581-607
spellingShingle basophil activation test
aspergillus spp.
aspergillus fumigatus
allergic bronchopulmonary aspergillosis
cystic fibrosis
fungal sensitization
Immunologic diseases. Allergy
RC581-607
Ya. I. Kozlova
E. V. Frolova
A. E. Uchevatkina
L. V. Filippova
O. V. Aak
T. S. Bogomolova
Yu. V. Borzova
V. R. Makhmutova
T. A. Stepanenko
V. D. Kuznetsov
N. V. Vasilyeva
M. V. Shulgina
N. N. Klimko
BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS
description Aspergillus fumigatus colonization in the patients with cystic fibrosis (CF) may cause sensitization against A. fumigatus and/or allergic bronchopulmonary aspergillosis (ABPA), which significantly worsens the course of underlying disease. At the present time, new diagnostic tests are searched for detection of fungal sensitization in these patients. The aim of this work was to evaluate an opportunity of application of basophile activation test with A. fumigatus allergen in vitro using flow cytometry, aiming for identification of fungal sensitization in the CF patients. The study included 190 patients with CF aged 1 to 37 years. All the patients underwent common allergy screening (skin tests with fungal allergens, determination of serum levels of total IgE and specific IgE for the fungal allergens), and mycological examination (microscopy and culture of respiratory substrates). Computed tomography of the chest was performed upon clinical indications. The basophil activation test with the A. fumigatus allergen was performed in 10 CF patients with ABPA, and 10 CF patients without ABPA, in addition to the standard allergological examination. Frequency of sensitization to A. fumigatus in the patients with cystic fibrosis was 27%, the incidence of allergic bronchopulmonary aspergillosis was 5.7%. The number of eosinophils, total IgE and specific IgE levels in CF patients with ABPA were significantly higher than in CF patients without ABPA. In blood of the ABPA patients we have identified 68.5 (52.5-81.5%) of basophilic leukocytes activated by A. fumigatus allergen, with a stimulation index of 17.07 (10.30-27.70). In appropriate comparison group, the stimulation index did not exceed 1.5 (p = 0.000). Direct positive correlation between the levels of specific IgE to A. fumigatus and the number of basophils activated by A. fumigatus allergens was revealed (r = 0.77; р < 0.05). FVC values and the body mass index in CF patients with ABPA were significantly lower when compared with the patients without fungal sensitization. Introduction of the basophil activation test, along with standard techniques, may enable a more differentiated assessment of ABPA development in CF patients. Timely detection of associations between A. fumigatus sensitization and clinical status of CF patients will facilitate early and effective administration of specific therapy.
format article
author Ya. I. Kozlova
E. V. Frolova
A. E. Uchevatkina
L. V. Filippova
O. V. Aak
T. S. Bogomolova
Yu. V. Borzova
V. R. Makhmutova
T. A. Stepanenko
V. D. Kuznetsov
N. V. Vasilyeva
M. V. Shulgina
N. N. Klimko
author_facet Ya. I. Kozlova
E. V. Frolova
A. E. Uchevatkina
L. V. Filippova
O. V. Aak
T. S. Bogomolova
Yu. V. Borzova
V. R. Makhmutova
T. A. Stepanenko
V. D. Kuznetsov
N. V. Vasilyeva
M. V. Shulgina
N. N. Klimko
author_sort Ya. I. Kozlova
title BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS
title_short BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS
title_full BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS
title_fullStr BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS
title_full_unstemmed BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS
title_sort basophile activation test for the diagnostics of fungal sensitization in the patients with cystic fibrosis
publisher SPb RAACI
publishDate 2019
url https://doaj.org/article/f29a786a592f4676bdf0ba3fccca289e
work_keys_str_mv AT yaikozlova basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT evfrolova basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT aeuchevatkina basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT lvfilippova basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT ovaak basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT tsbogomolova basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT yuvborzova basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT vrmakhmutova basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT tastepanenko basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT vdkuznetsov basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT nvvasilyeva basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT mvshulgina basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
AT nnklimko basophileactivationtestforthediagnosticsoffungalsensitizationinthepatientswithcysticfibrosis
_version_ 1718422328330682368